Related Experiment Video
Updated: May 31, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis: current situation, challenges and overview of its control programs in India
1Faculty of Medicine, Lund University, Lund, Sweden.
Journal of Global Infectious Diseases
|July 7, 2011
Summary
Tuberculosis (TB) remains a global pandemic and a leading infectious killer. India
Area of Science:
- * Global Health
- * Infectious Diseases
- * Public Health Policy
Background:
- Tuberculosis (TB) is an ancient infectious disease, persisting as a major global health threat and a leading cause of death, particularly among HIV-infected individuals.
- The World Health Organization (WHO) categorizes TB as a worldwide pandemic, highlighting its significant impact on global mortality rates.
Purpose of the Study:
- To review the historical progression and current status of tuberculosis control programs in India.
- To identify major challenges hindering TB eradication efforts in India.
- To examine the emergence of multidrug-resistant TB (MDR-TB) as a significant threat.
Main Methods:
- Consultation of data from official websites of the World Health Organization (WHO) and the Ministry of Health, Government of India.
- Literature search conducted using PubMed® and Google Scholar®.
Main Results:
- India's Directly Observed Treatment-Short Course (DOTS) program is the world's largest and fastest-expanding TB treatment initiative.
- Significant challenges to TB control in India include inadequate rural healthcare infrastructure, unregulated private sector drug use, HIV co-infection, and administrative issues.
- Multidrug-resistant TB (MDR-TB) is an escalating threat, often stemming from inadequate TB control programs.
Conclusions:
- Despite progress, TB eradication faces substantial obstacles in India, necessitating strengthened public health infrastructure and regulatory oversight.
- The WHO's "STOP TB" strategy aims for global TB elimination by 2050, requiring concerted international and national efforts.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: